Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-053111

Options or other derivatives

  • Director acquired 38,399 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Huang Andong Director 2022-10-05 Grant or award · Stock Option (Right to Buy) +38,399 38,399 D: show line 1 in the form
Loading xslF345X03/doc4.xml…